aspirin 325 mg

Generic: aspirin

Labeler: hyvee inc
NDC Directory HUMAN OTC DRUG OTC MONOGRAPH DRUG Inactive Finished

Drug Facts

Product Profile

Brand Name aspirin 325 mg
Generic Name aspirin
Labeler hyvee inc
Dosage Form TABLET, COATED
Routes
ORAL
Active Ingredients

aspirin 325 mg/1

Manufacturer
HYVEE INC

Identifiers & Regulatory

Product NDC 42507-018
Product ID 42507-018_484c020e-2b41-98c8-e063-6294a90a1a73
Product Type HUMAN OTC DRUG
Marketing Category OTC MONOGRAPH DRUG
Application Number M013
Listing Expiration 2027-12-31
Marketing Start 2026-01-13

Pharmacologic Class

Established (EPC)
nonsteroidal anti-inflammatory drug [epc] platelet aggregation inhibitor [epc]
Mechanism of Action
cyclooxygenase inhibitors [moa]
Chemical Structure
anti-inflammatory agents, non-steroidal [cs]
Physiologic Effect
decreased prostaglandin production [pe] decreased platelet aggregation [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 42507018
Hyphenated Format 42507-018

Supplemental Identifiers

RxCUI
212033
UPC
0075450825770
UNII
R16CO5Y76E
NUI
N0000000160 N0000008836 M0001335 N0000175722 N0000175578 N0000008832

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name aspirin 325 mg (source: ndc)
Generic Name aspirin (source: ndc)
Application Number M013 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 325 mg/1
source: ndc
Packaging
  • 1 BOTTLE, PLASTIC in 1 CARTON (42507-018-11) / 100 TABLET, COATED in 1 BOTTLE, PLASTIC
  • 500 TABLET, COATED in 1 PACKAGE (42507-018-15)
source: ndc

Packages (2)

42507-018-11 1 BOTTLE, PLASTIC in 1 CARTON (42507-018-11) / 100 TABLET, COATED in 1 BOTTLE, PLASTIC 42507-018-15 500 TABLET, COATED in 1 PACKAGE (42507-018-15)

Ingredients (1)

aspirin (325 mg/1)

Linked Drug Pages (1)

ASPIRIN 325 mg ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "484c020e-2b41-98c8-e063-6294a90a1a73", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832"], "upc": ["0075450825770"], "unii": ["R16CO5Y76E"], "rxcui": ["212033"], "spl_set_id": ["459d01df-6ff6-cff6-e063-6394a90ab35c"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["HYVEE INC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (42507-018-11)  / 100 TABLET, COATED in 1 BOTTLE, PLASTIC", "package_ndc": "42507-018-11", "marketing_start_date": "20260113"}, {"sample": false, "description": "500 TABLET, COATED in 1 PACKAGE (42507-018-15)", "package_ndc": "42507-018-15", "marketing_start_date": "20260113"}], "brand_name": "ASPIRIN 325 mg", "product_id": "42507-018_484c020e-2b41-98c8-e063-6294a90a1a73", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]"], "product_ndc": "42507-018", "generic_name": "ASPIRIN", "labeler_name": "HYVEE INC", "product_type": "HUMAN OTC DRUG", "brand_name_base": "ASPIRIN 325 mg", "active_ingredients": [{"name": "ASPIRIN", "strength": "325 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20260113", "listing_expiration_date": "20271231"}